Efficacy and safety of triamterene/ hydrochlorothiazide combinations in mild systemic hypertension

The American Journal of Cardiology(1989)

引用 1|浏览3
暂无评分
摘要
After a 3-week placebo lead-in (Period 1), 78 patients with sitting diastolic blood pressures (BPs) of ≥90 and ≤105 mm Hg entered a 4-week period (Period 2) during which they received triamterene (TMT) 37.5 mg/hydrochlorothiazide (HCTZ) 25 mg/day.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要